Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

4-piperazinemethyl-7-hydroxybenzofuran compound and medical application thereof

A technology of hydroxybenzene and compounds, applied in the field of compounds and their medical applications, can solve problems such as difficult to control intestinal symptoms

Active Publication Date: 2019-06-14
SHENYANG UNIV
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, Xenical is the best-selling pancreatic lipase inhibitor in the market, which has the characteristics of strong activity and good stability, but it also has the disadvantages of difficult-to-control intestinal symptoms, greasy stools, vomiting and abdominal distension.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • 4-piperazinemethyl-7-hydroxybenzofuran compound and medical application thereof
  • 4-piperazinemethyl-7-hydroxybenzofuran compound and medical application thereof
  • 4-piperazinemethyl-7-hydroxybenzofuran compound and medical application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0054] Example 1: Preparation of 4-[(4-phenylpiperazin-1-yl)methyl]-7-hydroxybenzofuran (B01)

[0055] Add 4.0 g (0.030mol) of 7-hydroxybenzofuran, 4.9 g (0.030mol) of 1-phenylpiperazine, 2.4 mL (0.033mol) of 37% aqueous formaldehyde solution, and 1 mL of glacial acetic acid into the reaction flask, and use an appropriate amount of ethanol as a solvent. Heat to reflux for 4~8h, TLC monitors the reaction process, after the reaction is completed, cool down, and remove ethanol by rotary evaporation to obtain a yellow oil, which is separated and purified by column chromatography with ethyl acetate:petroleum ether (1:5) as eluent , the solvent was removed by rotary evaporation, and 3.0 g of a light yellow solid was precipitated by freezing, with a yield of 32.5%. ESI-MSm / z: 309.2; 1H-NMR (CDCl3) δ(ppm): 2.62-2.67 (4H, m), 3.16-3.20 (4H, m), 3.56(2H, s), 6.70(1H, m) , 6.80(1H, d, J=8.1 Hz), 6.98-7.08(2H, m), 7.16-7.22 (4H, m), 7.68(1H, d, J=8.1 Hz).

Embodiment 2

[0056] Example 2: Preparation of 4-{[4-(4-methylphenyl)piperazin-1-yl]methyl}-7-hydroxybenzofuran (B02)

[0057]According to the preparation method of Example 1, a light yellow solid was obtained with a yield of 22.7%. ESI-MS m / z: 351.4; 1H-NMR(CDCl3) δ(ppm): 2.28 (3H, s), 2.67-2.72 (4H, m), 3.20-3.35 (4H, m), 3.60 (2H, s ), 6.70(1H, d, J=8.1 Hz), 6.96 (2H, d, J = 8.2 Hz), 7.00-7.06(2H, m), 7.16(2H, d, J=8.2 Hz), 7.72(1H , d, J=8.1 Hz).

Embodiment 3

[0058] Example 3: Preparation of 4-{[4-(2-methylphenyl)piperazin-1-yl]methyl}-7-hydroxybenzofuran (B03)

[0059] According to the preparation method of Example 1, a light yellow solid was obtained with a yield of 23.8%. ESI-MS m / z: 351.4; 1H-NMR(CDCl3) δ(ppm): 2.30 (3H, s), 2.60-2.68 (4H, m), 3.28-3.36 (4H, m), 3.66 (2H, s ), 6.56-6.64 (1H, m), 6.77(1H, d, J=8.1 Hz), 6.94-7.03(3H, m), 7.08-7.13(2H, m), 7.82(1H, d, J=8.1 Hz).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a 4-piperazinemethyl-7-hydroxybenzofuran compound and medical application thereof, and relates to a compound and medical application thereof. The compound comprises the 4-piperazinemethyl-7-hydroxybenzofuran compound shown as a formula I as well as stereoisomers and pharmaceutically acceptable salts of the compound. The formula I is shown in the description, wherein Ar is independently selected from phenyl, C1-C4 alkyl-substituted phenyl, C1-C4 alkoxy-substituted phenyl, halogen-substituted phenyl and cyano-substituted phenyl. The compound provided by the invention can be applied to effective lipase inhibition medicines, is especially used as a novel nutrient absorption reducing agent, can act on gastrointestinal tract, is capable of inhibiting catalysis and decomposition of lipase and inhibiting absorption of part of fat from dietary intake, is applicable to obesity, and is suitable for obese people including healthy obese people and obese people with non-insulin-dependent diabetes mellitus.

Description

technical field [0001] The invention relates to a compound and its medical use, in particular to a 4-piperazinemethyl-7-hydroxybenzofuran compound and its medical use. Background technique [0002] Obesity is a common disease worldwide. In recent years, the incidence of obesity has been increasing all over the world, especially in developed countries. Due to the rapid development of the economy and the continuous improvement of living standards, the problems of insufficient exercise and relative excess energy intake have always existed in the lifestyle of modern people, which has led to the energy intake of many modern people exceeding energy consumption, and the excess energy Part of it will be stored as fat in adipose tissue, leading to obesity, and obesity can cause a variety of metabolic abnormalities, which is one of the main risk factors for diabetes and cardiovascular diseases, and is associated with increased morbidity and mortality of cardiovascular diseases . At ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D307/79A61P3/04A61K31/496
Inventor 谭日红
Owner SHENYANG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com